Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CEFTRIAXONE

CEFTRIAXONE SODIUM

Standard Dose
EQ 2GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CEFTRIAXONE is listed in Drugs@FDA under application 202563 (ANDA).

Marketing status: Discontinued Active ingredient CEFTRIAXONE SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor HOSPIRA INC Submission history Latest submission status date: 2012-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFTRIAXONE is listed in Drugs@FDA under application 202563 (ANDA). Marketing status: Discontinued Active ingredient CEFTRIAXONE SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor HOSPIRA INC Submission history Latest submission status date: 2012-08-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.